ArticlebioRxiv : the preprint server for biology2026
Bayesian Estimation of Mosaic Loss of Chromosome Y from Bulk RNA Sequencing Data.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mosaic loss of chromosome Y (LOY) is a common age-associated somatic alteration in men and is typically measured from DNA-based assays. Many cohorts, however, contain bulk RNA-seq data without matched DNA-based LOY measurements. We developed a Bayesian framework to estimate the fraction of cells with LOY from male bulk RNA-seq by modeling reduced Y-linked gene expression relative to expected expression after adjustment for age, expression covariates, and autosomal/X-linked control genes. In 377 male GTEx samples, individual Y-linked genes showed negative correlations with separately obtained DNA-based LOY measurements, supporting a shared Y-expression depletion signal. The primary fast empirical Bayes estimator achieved a Pearson correlation of 0.678 with measured LOY, a mean absolute error of 1.79%, a root mean squared error of 3.72%, and 95.2% empirical coverage of measured LOY. Performance was strongest for identifying large LOY events, with an AUC of 0.964 for measured LOY greater than 20%, while fine ranking among low-LOY samples remained uncertain. A mixture/PCA hierarchical Bayesian sensitivity model provided similar validation performance and interpretable posterior quantities but did not improve point estimation. Leave-one-Y-gene-out and prior-sensitivity analyses showed that the signal was distributed across multiple Y-linked transcripts and that prior shrinkage affected calibration. In an external whole-blood RNA-seq dataset without measured LOY, estimated LOY showed a modest age-related increase, but ex vivo immune stimulation shifted RNA-derived LOY estimates and reduced multiple Y-linked transcripts, indicating transcriptional confounding. These results show that bulk RNA-seq contains usable information about LOY, especially for larger events, but RNA-derived LOY should be interpreted as a probabilistic transcriptome-based estimate rather than a direct substitute for DNA-based mosaicism measurement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.